BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11704872)

  • 1. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
    Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
    Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
    Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
    Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
    Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
    Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
    Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
    EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
    Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
    Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.
    Gombart AF; Grewal J; Koeffler HP
    J Leukoc Biol; 2007 Jun; 81(6):1535-47. PubMed ID: 17347301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.
    Haas M; Siegert M; Schürmann A; Sodeik B; Wolfes H
    Biochemistry; 2004 Jun; 43(25):8152-9. PubMed ID: 15209511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
    Kintscher J; Yamkamon V; Braas D; Klempnauer KH
    Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
    Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
    Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of c-Myb DNA-binding by RNA polymers.
    Nordgård O; Andersen TØ; Gabrielsen OS
    BMC Biochem; 2004 Nov; 5():15. PubMed ID: 15527501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
    Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells.
    Afroze T; Sadi AM; Momen MA; Gu S; Heximer S; Husain M
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1305-11. PubMed ID: 17363689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
    Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
    Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Id2 expression by CCAAT/enhancer binding protein beta.
    Karaya K; Mori S; Kimoto H; Shima Y; Tsuji Y; Kurooka H; Akira S; Yokota Y
    Nucleic Acids Res; 2005; 33(6):1924-34. PubMed ID: 15809228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.